I saw it was listed on HPTIs it possible to get liraglutide from grey vendors. I know its not nearly as effective from a results standpoint, but just curious.
Ah, I misinterpreted OP as saying gray lira is worse! And was surprised 🙂liraglutide is only 5-8 % weightloss, so much less effective for that.
Also, effect on appetite varies during the day because of the short halflife.
but it's not a bad drug, it does work.
Labcat, your user name says it, but I always misinterpret your pic. lol.Ah, I misinterpreted OP as saying gray lira is worse! And was surprised 🙂
Yes, that is my extra long orange tabby looking extra extra long stretched out on the couch, looking out the window.Labcat, your user name says it, but I always misinterpret your pic. lol.
Yes I have presbyopia. But I'm still not sure if it IS a cat or ??
That's a cute one !Yes, that is my extra long orange tabby looking extra extra long stretched out on the couch, looking out the window.
Now I’m a little afraid to ask… but no pain no gain… what does it look like 🤣?
🤣That's a cute one !
I'm not sure, it's a bit of a blur, but my thoughts weren't entirely pure, I have to admit. lol
First time I saw it, had to zoom in to make sure it was a lab cat lol
Well, he is more of a lap cat.First time I saw it, had to zoom in to make sure it was a lab cat lol
Phase 3 trials of liraglutide (the SCALE trial4) and semaglutide (the STEP 1 trial5) showed significant weight reduction at 56 weeks and 68 weeks, respectively, with a mean reduction of 9.2% with liraglutide and 16.9% with semaglutide. This phase 2 trial of orforglipron showed weight reduction ranging from 8.6% to 12.6% at 26 weeks and ranging from 9.4% to 14.7% at 36 weeks.
Google Gemini said:
Medication Phase Duration Mean Weight Loss Approx. Plateau Point Liraglutide Phase 3 56 Weeks ~8.0% – 9.2% ~28–32 Weeks Semaglutide Phase 3 68 Weeks ~14.9% – 16.9% ~60–68 Weeks Orforglipron Phase 3 72 Weeks ~12.4% – 14.7% ~60+ Weeks Tirzepatide Phase 3 72 Weeks ~20.9% – 22.5% ~72 Weeks Retatrutide Phase 2 48 Weeks ~24.2% Not yet reached
Google Gemini said:Lira is primarily used now as a "bridge" or for maintenance. Because it is a daily injection with a shorter half-life, it is much easier for doctors to "fine-tune" the dose for a patient who has already reached their goal weight and just needs enough GLP-1 activity to keep their hunger (ghrelin) in check without continuing to lose weight.
Some start on Lira because it’s cheaper or easier to manage daily. Once they hit that 28-week "poop out" point, they switch to Tirzepatide or Semaglutide.
I have two bottles of orfo. I have used a few pills at the end of the week and can confirm it does work. I was just curious if you could even get Liraglutide through grey vendors, given the popularity and effectiveness of sema, tirz, and reta.I would suggest orfo instead of lira. Orfo has a short half-life (though not as short as lira) while having more efficacy in the long term.
And orfo may be better for stacking, at least in theory. It seems orfo can share a GLP-1 receptor (since orfo is so small) with lira/sema/tirz/reta (which are much larger). But reta would still be better in the long term. Sooner or later, I plan to use lira and orfo together for shits and giggles.
I have used lira to avoid gaining weight while starting reta or other new things. I have also used it for stacking with no miracles to report. In the studies, lira does great in the beginning (like the same as the other GLPs for the first 12 weeks) but tends to "poop out" earlier than the other GLPs except for maintenance:
Medication Half-Life Short-Term Efficacy (12-16w) Long-Term Efficacy (40-72w) Reference Link Liraglutide (Lira) ~13 hours ~5% loss ~8.0% loss (56w) PMC 11642516 Orforglipron (Orfo) ~30–50 hours ~8-9% loss ~12.4% loss (72w) ATTAIN-1 (2025) Tirzepatide (Tirz) ~5 days ~12-15% loss ~20.2%–22.5% loss (72w) SURMOUNT-5 Survodutide (Survo) ~6 days ~8.7% loss (16w) ~14.9%–18.7% loss (46w) AJMC Phase 2 Retatrutide (Reta) ~6 days ~10% loss (12w) ~24.2%–28.7% loss (48-68w) NEJM Ph 2 / TRIUMPH Semaglutide (Sema) ~7 days ~6% loss ~14.9%–17.0% loss (68w) STEP 1 Trial Mazdutide (Maz) ~7–10 days ~5.2%–10.9% loss (12w) ~18.6%–21.0% loss (24w+) PMC 12515780
All the more exciting for us living on the edge, needing new feelz, haha. But so far, it seems like the other GLPs subjectively, as in the studies, just a shorter time frame.The only hesitation I might have about orforglipron is that although it accomplishes the same thing as GLP-1RA peptides, it is fundamentally different in that it's a drug designed to accomplish the same effect. Novo's pill is just a novel delivery mechanism to get a peptide from the stomach to the gut, so theoretically should have a similar risk profile to semaglutide. You can't really say the same thing about orforglipron. Although, I guess one could level the same critique about the newest peptides that add glucagon agonism too.